The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Live Webinar: Beating Cancer In Europe – Time to Deliver

The Cancer Drug Development Forum (CDDF) will hold a live webinar on “Beating Cancer in Europe – Time to deliver” on Monday 10 July 2023 at 6 PM (CEST) / 12 PM (EDT).


On February 2021, the European Commission published the “Europe’s Beating Cancer Plan” to enhance the EU commitment to cancer prevention, treatment and care. It is structured around four key action areas (prevention, early detection, diagnosis, and treatment, improve quality of life) and it is supported by ten flagship initiatives and multiple supporting actions.

Two years after the publication, the CDDF invites Dr Alberto Costa (European Commission, IT) who works closely with European Commissioner for Health and Food Safety Stella Kyriakidis, to share the perspective of the European Commission with a focus on the Europe’s Beating Cancer Plan’s history, the current status and the plans for the future in relation of the implementation of its recommendations.

Dr Costa’s lecture will be followed by a presentation by Prof. Mark Lawler (Queen’s University Belfast UK, CDDF Board Member) about the Lancet Oncology European Cancer Groundshot Commission on cancer research. This commission, the most comprehensive analysis of cancer research activity in Europe to date, has brought together a wide range of experts, together with detailed new data on cancer research activity across Europe during the past 12 years and has deployed this knowledge to set out an evidence-driven, patient-centred cancer research roadmap for Europe. After the presentations, a 30-minute panel discussion will be moderated by Teodora Kolarova (International Neuroendocrine Cancer Alliance (INCA), BU).

Agenda: (CEST time zone)

18:00 – 18:05     Introduction – Prof. Mark Lawler (Queen’s University Belfast UK, CDDF Board Member)

18:05 – 18:20     Presentation – Dr Alberto Costa (European Commission, IT)

18:20 – 18:35      Presentation – Prof. Mark Lawler (Queen’s University Belfast UK, CDDF Board Member)

18:35 – 19:00     Discussion – moderated by Teodora Kolarova (International Neuroendocrine Cancer Alliance (INCA), BU)

Dr Alberto Costa

Dr Costa is internationally recognised for his work for the advancement of breast cancer management and renowned for his innovative ideas in scientific communication and educational development and as Director of the European School of Oncology. He has served as Secretary General of the European Organisation for Research and Treatment of Cancer (EORTC) and as a member of the European Commission’s Europe Against Cancer programme. He is a member of the editorial boards of various cancer publications and author of over 250 scientific publications.

Prof. Mark Lawler

Mark Lawler is associate pro-vice-chancellor, professor of Digital Health, and chair in Translational Cancer Genomics, Queen’s University Belfast. Prof. Lawler has a strong commitment to patient-centred research/care and to addressing cancer inequalities. He was architect of the European Cancer Patient’s Bill of Rights, which he launched in the European Parliament with colleagues on World Cancer Day 2014. The Bill of Rights received the 2018 European Health Award, a prestigious award for partnerships that yield real health impact in Europe.

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70